The FDA will approve tamoxifen (Nolvadex) to PREVENT breast cancer

October 1998

The FDA will approve tamoxifen (Nolvadex) to PREVENT breast cancer...in high-risk women. It's already used for treatment.

Tamoxifen reduces the risk of developing breast cancer by almost HALF...in women who are at high risk.

But it can't be used indiscriminately...tamoxifen increases the risk of endometrial cancer and blood clots in women over 50.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote